Neurolief’s FDA-approved Proliv Rx offers at-home, non-invasive neuromodulation for adults with treatment-resistant depression, expanding access to personalized care beyond traditional medications.

GLP-1 medications provide effective weight loss, but stopping treatment may lead to modest weight regain, highlighting the importance of follow-up, lifestyle support, and individualized care.

BD’s ELYRA thulium fiber laser improves kidney stone surgery with quieter operation, compact design, efficient stone dusting, streamlined workflows, reduced retropulsion, faster procedures, and savings.

Coronary reactivity testing can uncover hidden vascular dysfunction in patients with persistent angina despite normal angiograms, enabling targeted treatment, reducing uncertainty, and lowering healthcare utilization.

A prenatal blood test analyzing placental biomarkers may help identify preeclampsia risk earlier, enabling proactive monitoring, targeted interventions, and improved maternal-fetal outcomes.

Intuitive’s da Vinci 5 updates extend instrument lifespan, strengthen cybersecurity, enhance remote collaboration, and improve surgical workflows, helping hospitals balance efficiency, safety, scalability, and costs.

Class I evidence supports EpiWatch, an Apple Watch–based seizure detection app that accurately identifies tonic-clonic seizures, minimizes false alarms, reduces caregiver fatigue, and improves safety.

New evidence suggests migraine, particularly with aura, remains an independent stroke risk factor in older adults, highlighting the need for lifelong cardiovascular risk assessment.

Political beliefs increasingly influence public trust in cancer science, highlighting the need for tailored health communication strategies that strengthen engagement, credibility, and evidence-based decision-making.

Pharmacist-led discharge programs improve medication safety and coordination after hospitalization, with targeted benefits for patients with low adherence, literacy challenges, and complex medication regimens.